SMS Pharmaceuticals Ltd (BOM:532815) Q2 2025 Earnings Call Highlights: Strong Revenue Growth …
Despite an 18% revenue increase, SMS Pharmaceuticals Ltd faces challenges with declining gross margins due to rising raw material costs and industry pressures.
